Back to the main directory
EarningsReview / Equity
- Telenor - Buy/NOK 172 (166): Solid Q1 paves the way for a positive 2025 by Nordea
- In the Flow by BNP Paribas Exane
- Ambea - Buy/SEK 125: Chugging along by Nordea
- Nordisk Bergteknik - Hold: Not extrapolating too much from Q1 by Nordea
- Coloplast - Hold: Uncertainty remains elevated by Nordea
- CEO Departure & Q1 results by BNP Paribas Exane
- 1Q25: sales beat; profit in line as Little Rock starts by BNP Paribas Exane
- Repsol (REP SM) by HSBC
- Strong start to the year by BNP Paribas Exane
- Invisio - Volatility, that’s just the way of this business by Danske Bank Equity Research
- Endesa - 1Q25 first take by BNP Paribas Exane
- Result in line. Guidance reiterated by BNP Paribas Exane
- Q1’25 results - Strong North American driven sales beat, margin guidance unchanged despite tariffs by BNP Paribas Exane
- FQ2 25 sales/EPS 2%/0% above cons., underlying b2b <1x (BNPPe) and low end of FY25 EPS guide cut by 6% on tariff by BNP Paribas Exane
- 2H25 results and FY26 EBITDA guidance in line by BNP Paribas Exane
- Q1'25 results: solid execution, weak FCF, more optimistic for sales 27-30e by BNP Paribas Exane
- 1Q25 first take: A decent quarter by BNP Paribas Exane
- 1Q key figures - first take by BNP Paribas Exane
- Osmosun - Des résultats nettement dégradés by MidCap Partners
- Bonduelle - Un troisième trimestre sans surprise by MidCap Partners
- Figeac Aero - No Surprise! by MidCap Partners
- Osmosun - Significantly degraded results by MidCap Partners
- Fluidra - Steady start amid tariff uncertainty; Neutral by JB Capital Markets
- Novo resets but consensus already at mid-point. Back to Rx watching by BNP Paribas Exane
- CHINA STIMULUS, NUE, STEEL EU, STEEL US, STAINLESS, SZG, STRATEGY by BNP Paribas Exane